Responses
Clinical and epidemiological research
Extended report
Predicting low disease activity and remission using early treatment response to antitumour necrosis factor therapy in patients with rheumatoid arthritis: exploratory analyses from the TEMPO trial
Compose a Response to This Article
Other responses
No responses have been published for this article.